This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany



Almac Sciences provides drug development services (small molecules & peptides) with expertise in small and large molecule analytics, API supply, stable & 14C radiolabelling, formulation development & solid-state services. Almac provide a full suite of analytical testing services across 3 FDA approved laboratories. Encompassing method development, validation, transfer and stability studies on small molecule, biologics, active ingredients and finished products (including controlled substances). Almac’s team of 170 analysts have the capacity and capability to deliver your project. In 2020 Almac announced the expansion of its existing suite of analytical solutions to include biologics testing. The biologic analytical services Almac can provide include GMP release and stability testing to support clients’ drug substance and drug product programs for both novel biologics and biosimilars; fit-for-purpose analytical method development / phase-appropriate method validation; raw material testing for microbial and mammalian expression systems that comply with pharmacopeial requirements.